Eiki Ichihara

  • 2181 Citations
  • 20 h-Index
20072019
If you made any changes in Pure these will be visible here soon.

Research Output 2007 2019

  • 2181 Citations
  • 20 h-Index
  • 75 Article
  • 2 Letter
  • 1 Comment/debate
  • 1 Review article
Filter
Letter
2019

Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Makimoto, G., Hotta, K., Oze, I., Ninomiya, K., Nakanishi, M., Hara, N., Kano, H., Watanabe, H., Hata, Y., Nishii, K., Nakasuka, T., Itano, J., Ninomiya, T., Kubo, T., Ohashi, K., Ichihara, E., Minami, D., Sato, A., Tabata, M., Maeda, Y. & 1 others, Kiura, K., Jan 1 2019, (Accepted/In press) In : Acta Oncologica.

Research output: Contribution to journalLetter

Patient Preference
Lung Neoplasms
Decision Making

Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma

Nakasuka, T., Ichihara, E., Makimoto, G., Maeda, Y. & Kiura, K., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. e168-e169

Research output: Contribution to journalLetter

Drug Therapy
CH5424802
Adenocarcinoma of lung
Bevacizumab